Icg Strategic Equity

What does Icg Strategic Equity invest in?

ICG Strategic Equity (ICGSE) is a specialist private-equity investor focused exclusively on the GP-led secondaries market. The strategy was launched in 2014 and focuses on structuring and leading single-asset continuation-vehicle secondary transactions.

ICGSE backs financial sponsors to extend the value-creation journey of selected private-equity assets while providing liquidity and investor-base realignment options for existing investors.[1]

The strategy is centered on single-asset continuation vehicles rather than a broad LP-portfolio purchase approach. ICGSE evaluates whether a sponsor has a strong history with an asset, whether the asset has been a consistent portfolio performer and whether it would benefit from additional time or capital.

Its stated transaction model supports a sponsor’s continued ownership of a selected asset while providing existing investors with liquidity or rollover options.[1][2]

Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.

What should a business owner evaluate before considering a transaction with Icg Strategic Equity?

An owner or sponsor evaluating a GP-led continuation vehicle should assess the fit between the proposed asset and ICG Strategic Equity’s stated focus on single-asset transactions, sponsor history, consistent portfolio performance and the potential need for additional time or capital.

The strategy’s stated regions, cited sector areas and disclosed transaction-size history are relevant points for an owner to clarify against the proposed company. The sources cited for this profile do not establish ICGSE’s current enterprise-value or equity-check ranges, valuation expectations, governance terms or required rollover structure.[1][2]

What companies does Icg Strategic Equity target?

Publicly stated evaluation factors include the sponsor’s history with the asset, the asset’s record as a consistent portfolio performer and whether the company would benefit from additional time or capital.

ICG Strategic Equity V targets single-asset continuation vehicles for high-quality companies in North America and Western Europe. ICGSE has stated that it has pursued single-buyer continuation-vehicle sizes up to $1.5 billion.[2][3]

ICG Strategic Equity states that it tends to gravitate toward healthcare, information technology, education, consumer staples, insurance services and business services. It describes these areas in the context of strong asset-level fundamentals.[2]

ICG Strategic Equity identifies North America and Western Europe as its regions. ICG’s fundraise announcement for ICG Strategic Equity V also identifies those regions as the target geography for the fund’s single-asset continuation-vehicle investments.

An official ICG presentation reported an estimated 70%/30% US-Europe geographic split for ICG Strategic Equity V as of February 2025.[1][3][4]

ICG Strategic Equity’s public strategy is organized around single-asset continuation vehicles. The cited materials describe sponsor-backed transactions involving selected private-equity assets and do not establish a separate platform-versus-add-on investment classification.[1][3]

Publicly identified examples include Ryan LLC, where ICG Strategic Equity partnered with Onex as lead investor in a single-asset continuation vehicle to acquire a co-control interest alongside management and Ares Management.

Another example is Gateway, a US-and-Canada veterinary-services business. ICG Strategic Equity partnered with Imperial Capital as lead investor in a single-asset continuation vehicle to acquire a majority interest; the investment year is identified as 2022.

In 2018, funds managed by ICG Strategic Equity agreed to purchase a portfolio of private-equity assets held on Standard Chartered’s balance sheet in connection with the spin-out of Affirma Capital. The transaction was valued at approximately £790m ($1bn) and covered 35 companies across multiple Asian, Middle Eastern and African markets.[5][6][7]

ICG’s public materials report six ICG Strategic Equity V transactions completed as of February 2025. The named case studies available in the cited materials include Ryan LLC and Gateway, while the Affirma Capital portfolio spin-out is identified as a 2018 transaction.

The Ryan and Gateway descriptions state that ICG Strategic Equity acted as lead investor in single-asset continuation vehicles to acquire interests in the respective businesses. The Affirma Capital announcement states that funds managed by ICG Strategic Equity agreed to purchase the Standard Chartered portfolio.[4][5][6][7]

What is not clear from Icg Strategic Equity's public investment criteria?

The cited 3 March 2025 ICG Strategic Equity V fundraise announcement discloses aggregate commitments, target geography and strategy, but does not disclose the names, purchase prices or consideration terms of individual ICG Strategic Equity V investments.

The current Strategic Equity page provides aggregate track-record and team metrics but does not publish a complete current portfolio-company list.[1][3]

Questions to ask when evaluating Icg Strategic Equity as a buyer or investment partner

Related Auxo guidance

Use these resources to evaluate role, structure, economics and process rather than relying on a directory profile alone.